Garnet E. Peck Symposium - 2005 Speaker Biographies

• Metin Çelik
• Allen Chao
• Charles Cunningham
• Michael J. Doyle
• Alice C. Martino
• Garnet E. Peck
• Carl Wassgren

Dr. Çelik is the founder and the president of Pharmaceutical Technologies International, Inc., and is also a research professor of pharmaceutical processing at the Department of Industrial and Systems Engineering, Rutgers University. Prior to that, he was a faculty member at the College of Pharmacy, Rutgers University. Dr. Çelik received his B.Sc.(Hons.) degree in Pharmacy from Hacettepe University-Turkey and was awarded a Ph.D. degree in Pharmaceutical Technology from Leicester Polytechnic-UK.

Dr. Çelik worked at Sandoz-Switzerland and Sandoz-Turkey before he joined Smith Kline & French Laboratories to establish the first state-of-art compaction simulator system in the western hemisphere. He developed the second unit at Rutgers as the first such unit in academia in the U.S.A. and established an internationally recognized research center.

Dr. Çelik has organized over forty national and international symposia and short courses, and has published over thirty publications including book chapters, and refereed research articles and made over hundred and fifty presentations (mostly invited) at the industry, academia, national and international meetings.

Dr. Çelik's recent areas of interests include: PAT (Process Analytical Technology); development of pharmaceutical expert systems, excipient databases, and management tools in the area of drug delivery technologies; use of compaction simulators in the preformulation and formulation of solid dosage forms; theory and practice of pharmaceutical compaction; excipient functionality testing; and pharmaceutical processing (including milling, mixing, granulation, tableting, and coating).

Dr. Çelik has acted as consultant to the FDA and to over forty-five pharmaceutical, nutraceutical, excipient, and equipment companies as well as law firms worldwide.

Dr. Çelik is currently serving as a member of the editorial board or as a reviewer for numerous pharmaceutical journals. He is the past chair of the AAPS Process Development Focus Group. Dr. Çelik is the founder and the past chair of the AAPS Expert Systems Focus Group, and the founder and the present chair of the AAPS Excipients Focus Group.

Dr. Çelik is listed in Who's Who in Science and Engineering (1995).

Dr. Allen Chao earned his doctoral degree in Industrial and Physical Pharmacy from Purdue in 1973. His wife, Lee Hwa-Chao, earned her bachelor's degree in Pharmacy from Purdue that same year. In 1983 Dr. Chao founded Watson pharmaceuticals, and in 1993 he took the company public. Watson is now a leading specialty pharmaceutical company with a balanced portfolio of branded and generic products, a strong sales and marketing presence and burgeoning branded product development activities. Dr. Chao was honored for his accomplishments by receiving the Entrepreneur of the Year Award representing Inland, California in 1994. In 2000, the School of Pharmacy awarded Dr. Chao an honorary doctor of science degree. He is also a Purdue University President's Council Distinguished Pinnacle Award winner.

Thanks to the generosity of Dr. and Mrs. Chao, Purdue has become one of just five universities in the country to blend pharmaceutical education and drug manufacturing through their gift establishing the Chao Center for Industrial Pharmacy and Contract Manufacturing in the Purdue Research Park.

Mr. Charles Cunningham is the Pharmaceutical Technical Services Manager for Colorcon North America. In his 12 years with Colorcon he has held both regional and global Technical Manager positions providing technical support for film-coating processes and solid oral dose formulation using immediate and modified release technologies supplied by Colorcon.

In his career at Colorcon Charles has focused on coating process applications and the scale-up and optimization of aqueous film-coating processes. Charles has also published several articles in the areas of film coating and excipient technologies. He holds 2 patents related to novel film-coating formulations.

Prior to joining Colorcon, Charles was employed by Niro and was involved in the development of spray-drying, fluid-bed coating and granulation processes.

Dr. Doyle received his Ph.D. in Natural Sciences from Cambridge University in 1989. Following graduation, he joined British Petroleum as a computational chemist, and in 1992 he moved to Molecular Simulations Inc. as manager of Technical Support. His career with Molecular Simulations brought him to the United States in 1993 as the Manager of Application Science. As manager, his duties included the deployment of molecular modeling to new accounts and support of MSI customers. His next position as Director, Formulations Consortium, gave him responsibility for the development and implementation of MSI strategy for the use of QSAR and data mining tools in atomistic, hybrid and formulation applications and for the development of MSI's Materials Combinatorial Chemistry business along with customer support. In 2001 Molecular Simulations became Accelrys. As Director of Business Development Materials Informatics, he is responsible for the Informatics product for all sales regions. His scientific interests include the use of crystallographic data for molecular modeling, crystal structure analysis and formulation design, and property prediction.

Dr. Doyle has two children, one of whom is at the University of California in San Diego. In his spare time he enjoys hiking.

Dr. Alice Martino earned her B.S. at Purdue University and her Ph.D. at the University of Iowa. She was employed by Upjohn, remained with the company when it became Pharmaceia & Upjohn, and now works with Pfizer following its acquisition of Pharmaceia & Upjohn. She has been with the company a total of nineteen years and is highly experienced in the area of pharmaceutical product development including solids and specific drug delivery systems.

Dr. Peck was born in Windsor, Ontario, Canada. He received his B.S. (1957) degree in Pharmacy from Ohio Northern University and the M.S. (1959) and Ph.D. degrees in industrial pharmacy from Purdue University. From 1962 to 1967 Dr. Peck was employed by the Mead Johnson Research Center, and in 1967 he returned to Purdue University to join the Department of Industrial and Physical Pharmacy. He was associate department head from 1989 to 1996 and director of the industrial pharmacy laboratory until he retired in 2003.

Dr. Peck's research interests include optimization of drug product design and process design, in particular those systems involving tablets: topical drug adsorption, flow of solid systems, dispersed systems design and evaluation, new tablet coating materials and procedures, and excipient-drug interaction. His research has resulted in over 150 scientific publications. Dr. Peck is a member of the APhA, the PT Section of the American Association of Pharmaceutical Scientists, ACS, AACP, New York Academy of Science, Sigma Xi, Rho Chi, Phi Lambda Upsilon, Phi Kappa Phi and is a Fellow of the AAAS, APRS, AAPS and the American Institute of Chemists. Dr. Peck was Chairman of the IPT Section of the Academy of Pharmaceutical Sciences for 1983-84. He was elected to the 1985-90 United States Pharmacopeia Committee of Revision and then re-elected to the committee for 1990-95 and 1995-2000. He was elected to the Committee of Experts, Excipients for 2000-05 and has been re-elected for the 2006-2010 term. He is currently a member of the Food and Drug Administration Advisory Committee, and is an expert witness for the FDA. Dr. Peck is a founding member of the Catholic Academy of Science in the United States which was established in 1987. On March 20,1994, the American Pharmaceutical Association awarded him the Sidney L. Riegelman Research Achievement Award in Pharmaceutics, and he received the Pharmaceutical Technology Publishers' Award in September, 1994.